Pricing Log in Create free account

Satellos Bioscience Inc. (MSLE) vs Protara Therapeutics, Inc. (TARA)

Satellos Bioscience Inc. and Protara Therapeutics, Inc. are both Biotechnology companies. Satellos Bioscience Inc. is the larger, with a market value of $152.6M against $135.9M — 1.1× the size. Across the 9 metrics below, Satellos Bioscience Inc. leads on 5 and Protara Therapeutics, Inc. on 4.

Valuation

Metric MSLE TARA Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 2.50 0.87 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.02 0.66
EV/Sales n/m n/m 9.02
Earnings yield (27.50%) (58.70%) (32.88%)
Free cash flow yield (19.37%) (47.40%) (23.13%)

Profitability

Metric MSLE TARA Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (70.45%) (45.80%) (51.96%)
Return on assets (64.76%) (42.05%) (46.06%)
Return on invested capital 0.00% (255.06%) 0.00%

Growth

Metric MSLE TARA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 21.20% 38.25% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MSLE TARA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.22 10.97 4.97
Net debt to EBITDA 1.05 2.38 1.01

Dividend

Metric MSLE TARA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MSLE TARA Biotechnology median
Market cap 152.57m 135.92m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack